MAPT and Cognitive impairment: Impairments in olfactory processing are amongst the very first clinical signs that occur in almost 100% of AD cases [11], with evidence that tau (NTF) pathology in the OB may be more important than amyloid pathology underlying the early olfactory deficit in AD, clearly preceding cognitive impairments [12,13,14,15].